Mark Lackner insider trades
Open-market stock purchases and sales by Mark Lackner, Chief Scientific Officer at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 21, 2020.
Recent trades
No open-market trades in the last 12 months.
Open-market stock purchases and sales by Mark Lackner, Chief Scientific Officer at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 21, 2020.
No open-market trades in the last 12 months.